首页 | 本学科首页   官方微博 | 高级检索  
检索        

来氟米特对实验性变态反应性脑脊髓炎小鼠T细胞亚群及Th1型细胞因子的影响
引用本文:袁正洲,李作孝,马勋泰,罗斌,胡高云,杨波,陈琪.来氟米特对实验性变态反应性脑脊髓炎小鼠T细胞亚群及Th1型细胞因子的影响[J].西部医学,2014(1):19-22.
作者姓名:袁正洲  李作孝  马勋泰  罗斌  胡高云  杨波  陈琪
作者单位:[1]泸州医学院附属医院神经内科,四川泸州646000 [2]泸州医学院附属医院介人科,四川泸州646000 [3]泸州医学院附属医院肝胆外科,四川泸州646000
基金项目:泸州市科矬创新茁子培育计划项目(2013-R-51(8/18)
摘    要:目的探讨来氟米特(Leflunomide,LEF)对实验性变态反应性脑脊髓炎(EAE)小鼠模型发病防治作用及可能的免疫学机制。方法将30只雌性C57BL/6小鼠随机分为EAE对照组及高、低剂量LEF防治组,每组10只。通过注射髓鞘少突胶质细胞糖蛋白35—55(MOG35—55)免疫介导构建EAE模型。从造模前三天开始起EAE对照组及高、低剂量LEF防治组分别予以生理盐水和LEF8mg/kg/d与2mg/kg/d灌胃,连续10天。观察小鼠发病情况及外周血中T细胞亚群及IFN-扎IL-2水平的变化。结果两组使用LEF小鼠临床症状较轻,发病高峰期外周血T细胞亚群CD4+、CD8+分布比例较EAE对照组明显升高(P〈O.01),CD4+/CD8+值明显降低(P〈O.01);发病高峰期外周血IL-2、INF-7含量较EAE对照组明显降低(P〈O.01),且高剂量组降低更明显(P〈O.01)。结论LEF对EAE具有防治作用,且效果与LEF剂量有关。其防治作用可能与调节T淋巴细胞亚群分布及抑制IFN—y、IL-2水平有关。

关 键 词:实验性变态反应性脑脊髓炎  多发性硬化  来氟米特  T细胞亚群  Th1型细胞因子

Effect of Leflunomide on T cell subsets and Thl-type cytokines in experimental allergic encephalomyelitis mice
Institution:YUAN Zheng-zhou , LI Zuo-xiao , MA Xun-ta, et al (1. Department of Neurology, The Affiliated Hospital of Luzhou Medical College, Luzhou 646000, Sichuan; 2. Department of Interventional Therapy, The Affiliated Hospital of Luzhou Medical College, Luzhou 646000, Sichuan; 3. Department of Hepatobiliary Surgery, The Affiliated Hospital of Luzhou Medical College, Luzhou 646000, Sichuan)
Abstract:Objective To investigate the effect of leflunomide on experimental allergic encephalomyelitis mice and the possible immunological mechanisms. Methods 30 female C57BL/6 mice were randomly divided into control group, the high and low close leflunomide treatment group, n= 10. By injection of myelin oligodendrocyte glyeoprotein 35-55 im- mune-mediated build EAE model. From the beginning three days before modeling EAE, control group and the high and low dose treatment group were feed saline, leflunomide 8 mg/kg/d, leflunomide 2mg/kg/d for 10 days. Incidence was observed in mice and peripheral blood T cell subsets and IFN-,IL-2 levels were detected. Results Each treatment group had mild clinical symptoms, and peripheral blood T cell subsets CD4+, CDS+ distribution were higher than EAE con- trol group (P〈0.01), CD4+/CDS+ value was lower (P〈O, 01) ; peripheral blood IL- 2, INF-y levels were significant- ly lower than EAE control group (P〈0. 01), and high dose reduction is more significant (P〈0.01). Conclusion Le- flunomide has preventive effect on EAE , and the effect is dose related with the leflunomide. Its preventive effect may be related to the regulation of T lymphocyte subsets and inhibition of IFN- and IL-2.
Keywords:Experimental allergic encephalomyelitis~ Multiple sclerosis~ Leflunomide~ T cell subsets~ Thl typecytokines
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号